Z1041: Study Drug Completion - Trastuzumab (SDCT) NCT00513292 Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder:


Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/27/15
Uploaded on:

June 27, 2015

No DOI assigned. To request one please log in.
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Z1041: Study Drug Completion - Trastuzumab (SDCT) NCT00513292

No Instruction available.

  1. StudyEvent: Z1041: Study Drug Completion - Trastuzumab (SDCT)
    1. No Instruction available.
Header Module
Study Drug Assessment
This form was completed based on information from
Were there any dose modifications or additions/omissions to protocol treatment?
Dose Modification Reason
Did the patient receive RT during this reporting period
Did the patient receive any hormone therapy during this reporting period?

Similar models